Jonathan S Leff's Net Worth

$31.9 Million

Who is Jonathan S Leff?

Jonathan S Leff has an estimated net worth of $31.9 Million. This is based on reported shares across multiple companies, which include Altus Pharmaceuticals Inc., ZYMOGENETICS INC, Nivalis Therapeutics, Inc., Larimar Therapeutics, Inc., PROTEON THERAPEUTICS INC, AveXis, Inc., SUNESIS PHARMACEUTICALS INC, ALLOS THERAPEUTICS INC, ARS Pharmaceuticals, Inc., Talon Therapeutics, Inc., NEUROGEN CORP, INSPIRE PHARMACEUTICALS INC, and INTERMUNE INC.

SEC CIK

Jonathan S Leff's CIK is 0001215242

Past Insider Trading and Trends

2008 was Jonathan S Leff's most active year for acquiring shares with 181 total transactions. Jonathan S Leff's most active month to acquire stocks was the month of February. 2010 was Jonathan S Leff's most active year for disposing of shares, totalling 12 transactions. Jonathan S Leff's most active month to dispose stocks was the month of September. 2009 saw Jonathan S Leff paying a total of $40,146,596.00 for 8,962,888 shares, this is the most they've acquired in one year. In 2011 Jonathan S Leff cashed out on 32,503,253 shares for a total of $114,537,440.00, their largest year based on trade value.